NCT00587314 2026-03-11
ablation IN BE
Mayo Clinic
Enrolling by invitation
Clinical Trials
180 trialsNCT05677490 2026-03-04
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT07282912 2026-03-04
OLIGOMETS
Yale University
Phase 2 Recruiting
NCT06523374 2026-02-24
Endeavor-1
University Hospital, Antwerp
Phase NA Recruiting
NCT06623396 2026-02-11
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT07375420 2026-02-02
OPTIMUS
University of Surrey
Phase NA Recruiting
NCT06824363 2026-01-30
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
University of California, Irvine
Phase EARLY_PHASE1 Not yet recruiting
NCT03961945 2026-01-26
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Mayo Clinic
Phase NA Recruiting
NCT07206589 2026-01-23
Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
Mayo Clinic
Phase NA Not yet recruiting
NCT07343869 2026-01-15
FEO
Société Française d'Endoscopie Digestive
Not yet recruiting
NCT07212491 2025-12-31
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Mayo Clinic
Enrolling by invitation
NCT07309991 2025-12-30
Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy
Sun Yat-sen University
Completed
NCT06161818 2025-12-22
TNT-OES-2
Erasmus Medical Center
Phase 2 Recruiting
NCT07059299 2025-12-19
NeoTISLEGA
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 1 Recruiting
NCT06071845 2025-12-16
SOS4C
Mayo Clinic
Phase NA Recruiting
NCT06532734 2025-12-10
Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
Denver Health and Hospital Authority
Recruiting
NCT07260734 2025-12-03
AROMA2
Imperial College London
Not yet recruiting
NCT06251973 2025-12-02
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06846346 2025-11-28
GRACIE
UNICANCER
Phase 2 Recruiting
NCT06687603 2025-11-13
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Case Comprehensive Cancer Center
Phase NA Recruiting
NCT07223424 2025-11-10
PSI-Immune
University of Pittsburgh
Phase 2 Recruiting
NCT03161522 2025-10-23
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04408105 2025-10-22
SCREEN-BE
University of Colorado, Denver
Completed
NCT05051475 2025-10-03
RATE
Centre of Postgraduate Medical Education
Phase NA Completed
NCT07159711 2025-09-08
SEISMIC
Guy's and St Thomas' NHS Foundation Trust
Not yet recruiting
NCT02962063 2025-09-05
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
NCT04929392 2025-09-04
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06687876 2025-07-10
MEMENTO
Amsterdam UMC, location VUmc
Phase 2 Recruiting
NCT02366819 2025-06-13
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
University of Chicago
Phase 4 Recruiting
NCT05067842 2025-06-08
TRACT DNA
Medical College of Wisconsin
Withdrawn
NCT05524844 2025-05-11
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Columbia University
Completed
NCT06933966 2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2 Not yet recruiting
NCT03429816 2025-03-27
OPPOSITE
University Hospital Heidelberg
Phase NA Completed
NCT06289374 2025-02-19
LABS
Imperial College London
Recruiting
NCT04114136 2025-02-10
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
University of Pittsburgh
Phase 2 Recruiting
NCT06702384 2025-02-06
MAGnET
Royal Marsden NHS Foundation Trust
Withdrawn
NCT06642506 2024-11-12
Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma
Ludwig-Maximilians - University of Munich
Active not recruiting
NCT03366012 2024-11-08
REACT
Columbia University
Phase NA Terminated
NCT05476796 2024-10-24
LOGICAN
UNICANCER
Phase 2 Recruiting
NCT05713838 2024-09-19
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Recruiting
NCT01404156 2024-08-28
POWERRANGER
CancerCare Manitoba
Phase 2/3 Completed
NCT05177133 2024-08-02
AuspiCiOus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Recruiting
NCT03641547 2024-07-18
CHARIOT
University of Oxford
Phase 1 Completed
NCT05530343 2024-06-12
SWAT-BE
University of Colorado, Denver
Phase NA Recruiting
NCT06381583 2024-05-10
EMERALD
City of Hope Medical Center
Completed
NCT04159974 2024-05-09
RICE
University of Cologne
Phase 2 Unknown
NCT02509286 2024-05-08
ESOPEC
University Hospital Schleswig-Holstein
Phase 3 Active not recruiting
NCT03060642 2024-04-05
BETRNet2
Columbia University
Completed
NCT02735239 2024-03-22
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
Ludwig Institute for Cancer Research
Phase 1/2 Completed
NCT03339843 2024-03-15
MiMe-A
Jules Bordet Institute
Phase 2 Completed